Delivery Order SPE2DB20D7059-SPE2DB25FQMG2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,244.93 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.39 to AmerisourceBergen Drug Corp on July 30, 2025, for Refresh Plus 0.5% eye drops (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, supporting federal medical procurement requirements for military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,870.98 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-unit supply) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for Refresh Plus 0.5% Eye Drops (30-count units) valued at $2,483.11. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the contractor's Corporate Office location in Conshohocken, PA. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,545.63 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on July 21, 2025, with a completion date of July 22, 2025. This firm fixed price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $1,650.33 delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-competitive set-aside and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,041.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $1,719.02 delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (70 unit dose vials) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a $579 delivery order to Amerisourcebergen Drug Corporation for REFRESH PLUS 0.5% eye drops. The firm fixed price order is to supply 30 single-count bottles of the eye drops. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period from July 6 to July 7, 2023. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, Amerisourcebergen will fulfill this order to...
- This delivery order awards $1,232.34 to AmerisourceBergen Drug Corp for the supply of Refresh Plus 0.5% eye drops (70 unit dose containers) under a firm fixed price contract with the Defense Logistics Agency (DLA). The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQMG2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,715.27 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-unit package) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal medical procurement contracts with the Defense Logistics Agency and related defense health systems. The company's federal contract awards demonstrate extensive capability in supplying pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare needs. This eye drops delivery order represents a routine pharmaceutical supply fulfillment within the broader context of AmerisourceBergen's role as a prime pharmaceutical vendor for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/28/25 |